Year |
Citation |
Score |
2023 |
Yang JH, Hayano M, Griffin PT, Amorim JA, Bonkowski MS, Apostolides JK, Salfati EL, Blanchette M, Munding EM, Bhakta M, Chew YC, Guo W, Yang X, Maybury-Lewis S, Tian X, ... ... Rego MA, et al. Loss of epigenetic information as a cause of mammalian aging. Cell. PMID 36638792 DOI: 10.1016/j.cell.2022.12.027 |
0.311 |
|
2020 |
Fan M, Guerin K, Rego M, Bourges D, Ersing I, Haery L, Harten DeMaio K, Sanders E, Tasissa M, Kostman M, Tillgren M, Makana Hanley L, Mueller I, Mitsopoulos A. A novel next generation sequencing and analysis platform to assess the identity of rAAV preparations from rAAV DNA extracts. Human Gene Therapy. PMID 32159396 DOI: 10.1089/Hum.2019.277 |
0.302 |
|
2017 |
Vierra DA, Garzon JL, Rego MA, Adroved MM, Mauro M, Howlett NG. Modulation of the Fanconi anemia pathway via chemically induced changes in chromatin structure. Oncotarget. 8: 76443-76457. PMID 29100324 DOI: 10.18632/Oncotarget.19470 |
0.724 |
|
2017 |
Vierra DA, Garzon JL, Rego MA, Adroved MM, Mauro M, Howlett NG. Modulation of the Fanconi anemia pathway via chemically induced changes in chromatin structure. Oncotarget. PMID 28778076 DOI: 10.18632/oncotarget.19470 |
0.724 |
|
2013 |
Boisvert RA, Rego MA, Azzinaro PA, Mauro M, Howlett NG. Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal. Plos One. 8: e81387. PMID 24278431 DOI: 10.1371/Journal.Pone.0081387 |
0.713 |
|
2012 |
Rego MA, Kolling FW, Vuono EA, Mauro M, Howlett NG. Regulation of the Fanconi anemia pathway by a CUE ubiquitin-binding domain in the FANCD2 protein. Blood. 120: 2109-17. PMID 22855611 DOI: 10.1182/Blood-2012-02-410472 |
0.708 |
|
2012 |
Mauro M, Rego MA, Boisvert RA, Esashi F, Cavallo F, Jasin M, Howlett NG. p21 promotes error-free replication-coupled DNA double-strand break repair. Nucleic Acids Research. 40: 8348-60. PMID 22735704 DOI: 10.1093/Nar/Gks612 |
0.723 |
|
2012 |
Rego MA, Harney JA, Mauro M, Shen M, Howlett NG. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor. Oncogene. 31: 366-75. PMID 21685936 DOI: 10.1038/Onc.2011.237 |
0.759 |
|
2010 |
Rego MA, Mauro M, Harney JA, Shen M, Kolling FW, Howlett NG. Abstract LB-102: The p21Cip1/Waf1cyclin-dependent kinase inhibitor is required for the activation of the FA-BRCA pathway Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-102 |
0.716 |
|
2009 |
Howlett NG, Harney JA, Rego MA, Kolling FW, Glover TW. Functional interaction between the Fanconi Anemia D2 protein and proliferating cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. The Journal of Biological Chemistry. 284: 28935-42. PMID 19704162 DOI: 10.1074/Jbc.M109.016352 |
0.733 |
|
2009 |
Rego MA, Kolling FW, Howlett NG. The Fanconi anemia protein interaction network: casting a wide net. Mutation Research. 668: 27-41. PMID 19101576 DOI: 10.1016/J.Mrfmmm.2008.11.018 |
0.719 |
|
Show low-probability matches. |